Endocannabinoid System Clinical Research in Back Pain
Clinical research on full-spectrum cannabis extract back pain treatment shows meaningful pain reduction in chronic low back pain patients. The VER-01 extract demonstrated safety and tolerability over 12 weeks. These findings support further investigation…
Endocannabinoid System Clinical Research Overview
This overview covers endocannabinoid system clinical trials focusing on mental health and substance use disorders. Current evidence shows limited support for cannabinoids as primary treatments. More rigorous trials are needed to clarify safety and…
Evidence-Based Study on Cannabidiol and Glucose Tolerance
The cannabidiol glucose tolerance study examined the impact of low-dose CBD on glucose metabolism in sedentary adults with overweight or obesity. Results showed no significant improvements in glucose tolerance or gut microbiome changes. This study…
Endocannabinoid System Clinical Research: Pain Management Trial
The full-spectrum cannabis extract pain trial demonstrated significant pain reduction in adults with chronic low back pain. VER-01 was well-tolerated with manageable adverse effects. These findings support full-spectrum cannabis extract pain as a…
Brain-Body Integromics of the Ayahuasca Experience
Brain-body integration ayahuasca effects reveal how this psychoactive brew induces coordinated changes across biological systems. This study maps metabolism, brain connectivity, and subjective experience in ayahuasca users. Understanding these effects is…
Prenatal Cannabis Exposure and Autism Development Insights
Prenatal cannabis exposure autism is linked to increased behavioral and developmental concerns in children. Maternal cannabis use during pregnancy shows stronger associations in children with autism spectrum disorder symptoms. These findings highlight…
Cannabidiol Effects on Autism Anxiety and Parental Stress
This study examines effects cannabidiol autism anxiety parental stress in children aged 5-12 years. CBD oil at 10 mg/kg/day showed improvements in social relating and anxiety symptoms. Parental stress levels also decreased compared to placebo in this…
Endocannabinoid System and Psychosis Risk: Clinical Evidence
Cannabis induced psychosis significantly increases the risk of developing schizophrenia spectrum and bipolar disorder. Clinical evidence highlights the need for careful diagnostic evaluation and monitoring. Early identification of cannabis induced…
Digital Smoking Cessation Tools for HIV: Research and Impact
Digital smoking cessation tools HIV research highlights tailored interventions for people living with HIV. These tools improve reach and engagement in this high-risk group. Mobile-based digital therapeutics show promise for overcoming traditional…
Understanding Cannabidiol Supplement Use and WADA Drug Testing Results
Cannabidiol supplements and WADA-prohibited cannabinoids pose doping risks for athletes. Broad-spectrum CBD products can lead to positive anti-doping tests due to trace cannabinoids. Athletes should prefer CBD isolate to avoid unintended WADA violations.